diagnosis

David Araten, MD

Institution
NYU School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. David Araten is an assistant professor in the Division of Hematology at the NYU School of Medicine in New York City. Prior to holding this position, he worked as an assistant professor and instructor in hematology at Memorial Sloan-Kettering Cancer Center, also in New York City. His residency was in internal medicine at Columbia-Presbyterian Medical Center and received his medical degree from Harvard Medical School in Boston. Dr. Araten’s research has focused largely on PNH and he has published in a wide variety of peer reviewed journals on this topic. He is also a recipient of the 1997

Regis Peffault de Latour, MD, PhD

Institution
Hôpital Saint-Louis
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Peffault de Latour is a full Professor of Hematology in the Hematology and Bone Marrow Transplant Department of the Saint-Louis Hospital, Paris Address Service Hématologie-Greffe, Hôpital Saint Louis regis.peffaultdelatour@aphp.fr

Rafael Bejar, MD, PhD

Institution
UC San Diego Health
Physician Status
accepting new patients
Primary Disease Area of Focus
Myelodysplastic Syndromes (MDS)
About
Dr. Rafael Bejar, MD, PhD, is board-certified in internal medicine, oncology, and hematology, with a special interest in hematologic malignancies (blood cancers). He specializes in the care of patients with myelodysplastic syndromes (MDS) and related blood disorders. Dr. Bejar has established a MDS Center of Excellence at UC San Diego Health focused on providing the best diagnostic tools, supportive care, clinical trials, and medical expertise in one center. Dr. Bejar is a physician scientist who in addition to caring for patients, runs a research laboratory dedicated to the study of MDS. His

Gregory Abel, MD, MPH

Institution
Dana-Farber Cancer Institute
Physician Status
accepting new patients
Primary Disease Area of Focus
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.

Carlos DeCastro, MD

Institution
Duke University Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Subscribe to diagnosis

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.